Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

NFKB1 gene single-nucleotide polymorphisms: implications for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

A. Kuba, L. Raida, F. Mrazek, P. Schneiderova, E. Kriegova, K. Langova, T. Furst, J. Furstova, E. Faber, T. Papajik,

. 2020 ; 99 (3) : 609-618. [pub] 20200130

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005562

Grantová podpora
MHCZ-DRO (FNOl, 00098892) Ministerstvo Zdravotnictví Ceské Republiky

Graft-versus-host disease (GVHD) represents a significant cause of mortality after allogeneic hematopoietic stem cell transplantation (HSCT). NF-kB system is a master regulator of innate immunity responses. It controls the expression of various cytokines and chemokines many of which are involved in GVHD pathogenesis. Chemo(radio) therapy administered during conditioning induces DNA damage and activates DNA damage response (DDR) signaling resulting in irreversible cell cycle arrest - cellular senescence which has been described to be associated with robust pro-inflammatory secretion mostly controlled by NF-kB. The NFKB1 gene encodes the DNA-binding subunit of the NF-kB complex. Using the candidate gene approach, we analyzed possible association of two single-nucleotide polymorphisms (SNPs) rs3774937 C/T and rs3774959 A/G of the NFKB1 gene with GVHD and transplant-related mortality (TRM) occurrence in 109 recipients allografted from HLA-identical donor. Both SNPs in recipients were found to be strongly associated with acute GVHD. Nevertheless, no significant association with chronic GVHD and TRM was found. Presented pilot results contribute to pre-clinical observations and suggest that NF-kB may be an important regulator of HSCT-related inflammatory reactions such as acute GVHD. Novel pathogenic mechanisms of GVHD may arise from perspectives of DDR and cellular senescence where NF-kB plays an essential role.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005562
003      
CZ-PrNML
005      
20201013121459.0
007      
ta
008      
200511s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00277-020-03935-5 $2 doi
035    __
$a (PubMed)32002656
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Kuba, Adam $u Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. adam.kuba@fnol.cz.
245    10
$a NFKB1 gene single-nucleotide polymorphisms: implications for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation / $c A. Kuba, L. Raida, F. Mrazek, P. Schneiderova, E. Kriegova, K. Langova, T. Furst, J. Furstova, E. Faber, T. Papajik,
520    9_
$a Graft-versus-host disease (GVHD) represents a significant cause of mortality after allogeneic hematopoietic stem cell transplantation (HSCT). NF-kB system is a master regulator of innate immunity responses. It controls the expression of various cytokines and chemokines many of which are involved in GVHD pathogenesis. Chemo(radio) therapy administered during conditioning induces DNA damage and activates DNA damage response (DDR) signaling resulting in irreversible cell cycle arrest - cellular senescence which has been described to be associated with robust pro-inflammatory secretion mostly controlled by NF-kB. The NFKB1 gene encodes the DNA-binding subunit of the NF-kB complex. Using the candidate gene approach, we analyzed possible association of two single-nucleotide polymorphisms (SNPs) rs3774937 C/T and rs3774959 A/G of the NFKB1 gene with GVHD and transplant-related mortality (TRM) occurrence in 109 recipients allografted from HLA-identical donor. Both SNPs in recipients were found to be strongly associated with acute GVHD. Nevertheless, no significant association with chronic GVHD and TRM was found. Presented pilot results contribute to pre-clinical observations and suggest that NF-kB may be an important regulator of HSCT-related inflammatory reactions such as acute GVHD. Novel pathogenic mechanisms of GVHD may arise from perspectives of DDR and cellular senescence where NF-kB plays an essential role.
650    _2
$a dospělí $7 D000328
650    _2
$a alografty $7 D064591
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nemoc štěpu proti hostiteli $x genetika $x mortalita $x terapie $7 D006086
650    12
$a transplantace hematopoetických kmenových buněk $7 D018380
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a NF-kappa B - podjednotka p50 $x genetika $7 D052002
650    _2
$a pilotní projekty $7 D010865
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a míra přežití $7 D015996
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Raida, Ludek $u Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Mrazek, Frantisek $u Department of Immunology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Schneiderova, Petra $u Department of Immunology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Kriegova, Eva $u Department of Immunology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Langova, Katerina $u Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Fürst, Tomáš, $d 1978- $7 mzk2005286891 $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University, Olomouc, Czech Republic.
700    1_
$a Fürstová, Jana $7 _AN042275 $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University, Olomouc, Czech Republic.
700    1_
$a Faber, Edgar $u Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Papajik, Tomas $u Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
773    0_
$w MED00000424 $t Annals of hematology $x 1432-0584 $g Roč. 99, č. 3 (2020), s. 609-618
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32002656 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20201013121430 $b ABA008
999    __
$a ok $b bmc $g 1524420 $s 1095618
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 99 $c 3 $d 609-618 $e 20200130 $i 1432-0584 $m Annals of hematology $n Ann Hematol $x MED00000424
GRA    __
$a MHCZ-DRO (FNOl, 00098892) $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...